Home › Funds › Mink Brook Asset Management LLC › IRD
Mink Brook Asset Management LLC position in IRD
OPUS GENETICS INC · Health Care
Mink Brook Asset Management LLC reported holding 161,205 shares of IRD (OPUS GENETICS INC) in its Q2 2026 13F filing — a position valued at US$663K, representing 0.29% of its reported portfolio and ranking #39 among its reported holdings. Mink Brook Asset Management LLC has disclosed IRD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Mink Brook Asset Management LLC's IRD position evolved
Mink Brook Asset Management LLC first disclosed a stake in IRD in Q1 2025 at 810,080 shares (US$795K). The position peaked in Q4 2025 at 1,665,631 shares, worth US$3.3M. Across 6 filings, Mink Brook Asset Management LLC increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 161,205 shares valued at US$663K — a reduction of -429,347 shares quarter over quarter.. Notable position changes include a 48% increase in Q2 2025 (shares rose 76% over the following quarter), a 65% trim in Q1 2026 (shares fell 10% over the following quarter), a 73% trim in Q2 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 810.08K | $795.34K | New |
| Q2 2025 | 1.20M | $1.13M | Add |
| Q3 2025 | 1.24M | $2.04M | Add |
| Q4 2025 | 1.67M | $3.35M | Add |
| Q1 2026 | 590.55K | $2.69M | Reduce |
| Q2 2026 | 161.21K | $662.55K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- Caligan Partners LP 6.08M sh · $24.98M · Q2 2026
- BIOS Capital Management, LP 3.68M sh · $15.14M · Q2 2026
- Boxer Capital Management, LLC 2.81M sh · $11.57M · Q2 2026
- Trails Edge Capital Partners, LP 2.74M sh · $11.28M · Q2 2026
- GREAT POINT PARTNERS LLC 1.97M sh · $8.10M · Q2 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- Bleichroeder LP 736.84K sh · $3.03M · Q2 2026
More on Mink Brook Asset Management LLC
FAQ
How long has Mink Brook Asset Management LLC held IRD?
Mink Brook Asset Management LLC has disclosed IRD holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Mink Brook Asset Management LLC's current position in IRD?
As of Q2 2026, Mink Brook Asset Management LLC holds 161.21K shares of IRD (OPUS GENETICS INC), valued at $662.55K, representing 0.29% of its reported portfolio and ranking #39.
Has Mink Brook Asset Management LLC been buying or selling IRD?
In the latest 13F filing (Q2 2026), Mink Brook Asset Management LLC reduced its position in IRD. The position peaked in Q4 2025 at 1.67M shares.
Which other funds hold IRD?
Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.